Investors & Media
Gritstone bio, Inc. (Nasdaq: GRTS) is working to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors. Independently and with our partners, we are advancing a portfolio of product candidates with the aim of improving patient outcomes and eliminating disease.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
March 15, 2023
March 9, 2023
March 2, 2023